SALINAS, Calif.—Next Pharmaceuticals announced the results of an open label study on Relora®, which included 1,291 participants who suffered from stress, sleeplessness and/or stress-related eating. The study was conducted at the LaValle Metabolic Institute in Cincinnati. Ninety-one percent of the subjects reported Relora, a patented blend of Magnolia bark extract and a proprietary blend of Pellodendron bark extract, helped them relax, while 90 percent said it helped them have a restful sleep. Eighty-six percent reported Relora helped prevent stress-related eating.
“This study demonstrates Relora can be a successful adjunct for individuals who experience stress and anxiety, or who turn to food when dealing with tension,” said Charles Kosmont, CEO of Next Pharmaceuticals. “ There are many methods to managing stress, and this clinical study supports the fact that Relora is a natural, safe and effective approach with no toxic side effects.”
SALINAS, Calif.—
Next Pharmaceuticals announced the results of an open label study on Relora®, which included 1,291 participants who suffered from stress, sleeplessness and/or stress-related eating. The study was conducted at the LaValle Metabolic Institute in Cincinnati. Ninety-one percent of the subjects reported Relora, a patented blend of Magnolia bark extract and a proprietary blend of Pellodendron bark extract, helped them relax, while 90 percent said it helped them have a restful sleep. Eighty-six percent reported Relora helped prevent stress-related eating.
Email this article
Add a comment
Printer version
Order reprints
RSS Feed
Bookmark article